Precision Genomics delivers never-before-seen capabilities for early diagnosis, prevention and treatment of humanity’s most prevalent diseases
Using m-RNA inflammatory genetic markers to assist in disease diagnosis, monitoring, and assessment of pre and post- treatment responses.
With the help of artificial intelligence (AI), the proprietary PG mRNA Inflammatory Index™ is able to modulate key indicators with coordinating therapy. Using the most effective, personalized plan of care the first time.
With a truly unique array of new technologies and Bioinformatics, Precision Genomics is set up to become a dominant force in the medical field. From enabling revolutionary research to becoming the premier data bank to Big Pharma—the rolodex of groundbreaking solutions is deep. And thanks to unmatched insight into inflammation, Precision Genomics is always positioned at the heart of medicine’s most decisive problems.
Precision Genomics employs some of the best minds in the field. Meet the key individuals allowing us to make a habit of industry-leading innovation:
The PG mRNA Inflammatory Index™ compares snapshots at moments in time during the diseases’ process, measuring mRNA inflammatory markers.
By using the PG mRNA Inflammatory Index™ to match disease with its unique fingerprint mRNA, treatment can be personally modified based on the patient’s individual genetic makeup.
Dr. Hausman is an Immunologist and Board-Certified Urological Surgeon with more than 30 years of experience in drug research and development. He worked for some of the best pharmaceutical companies, including Bristol-Myers International, Mead-Johnson Pharmaceutical Co., E.R. Squibb, Medco Research, and Axonyx.
Dr. Ambert is currently Director of Data Science at Nike, Inc. and has extensive experience in data analytics, machine learning, artificial intelligence and applied analytics. Previously, he held positions at the National Library of Medicine and Intel Corp. Dr. Ambert holds a PhD in Biomedical Informatics from Oregon Health & Science University.